Literature DB >> 21679129

Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument.

Paulo Caleb Junior Lima Santos1, Renata Alonso Gadi Soares, Jose Eduardo Krieger, Elvira Maria Guerra-Shinohara, Alexandre Costa Pereira.   

Abstract

BACKGROUND: The genotyping of HFE p.C282Y and p.H63D mutations is one of the most requested molecular analyses in the laboratorial routine. In this scenario, the main aim was to develop a genotyping assay that has advantages compared to other methods.
METHODS: Genotypes for the HFE p.C282Y (c.G845A; rs1800562) and p.H63D (c.C187G, rs1799945) mutations were assessed by polymerase chain reaction (PCR) followed by high resolution melting (HRM) analysis with the Rotor-Gene 6000(®) instrument. Validation studies were conducted in samples bi-directionally sequenced.
RESULTS: The melting assay was developed in a unique procedure and to ensure the result in approximately 112 min (31 min for sample preparation and 81 min for the PCR-HRM step). Genotypes for the HFE p.C282Y mutation were easily distinguished in the region of 80-86°C. For the HFE p.H63D, genotypes were also easily distinguished in the region of 76-82°C, but using the addition of known wild-type genotype DNA in all unknown samples plus a reaction without addition. In validation, genotypes were 100% concordant between methods.
CONCLUSIONS: Our genotyping assay with the Rotor-Gene 6000(®) instrument applies to the laboratorial routine with several advantages, especially in large-scale demand. The main advantages were the non-dependence on gel electrophoresis and on mutagenic reagents for visualization of fragments, reduction of the chances for contamination due to sample preparation, the lack of use of probe-based methods and cost-effectiveness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21679129     DOI: 10.1515/CCLM.2011.654

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

1.  Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.

Authors:  Letícia C Tavares; Nubia E Duarte; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo Caleb Junior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2018-07-26       Impact factor: 2.953

2.  CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.

Authors:  Paulo Caleb Junior Lima Santos; Carla Luana Dinardo; Isolmar Tadeu Schettert; Renata Alonso Gadi Soares; Liz Kawabata-Yoshihara; Isabela Martins Bensenor; José Eduardo Krieger; Paulo Andrade Lotufo; Alexandre Costa Pereira
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

3.  MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population.

Authors:  Paulo C J L Santos; Theo G M Oliveira; Pedro A Lemos; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2012-06-28       Impact factor: 3.876

Review 4.  Molecular diagnostic and pathogenesis of hereditary hemochromatosis.

Authors:  Paulo C J L Santos; Jose E Krieger; Alexandre C Pereira
Journal:  Int J Mol Sci       Date:  2012-02-01       Impact factor: 6.208

5.  SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.

Authors:  Paulo C J L Santos; Renata A G Soares; Raimundo M Nascimento; George L L Machado-Coelho; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2011-10-12       Impact factor: 2.103

6.  Gender-related associations of genetic polymorphisms of α-adrenergic receptors, endothelial nitric oxide synthase and bradykinin B2 receptor with treadmill exercise test responses.

Authors:  Rafael Amorim Belo Nunes; Lúcia Pereira Barroso; Alexandre da Costa Pereira; José Eduardo Krieger; Alfredo José Mansur
Journal:  Open Heart       Date:  2014-12-22

7.  Quality of life scores differs between genotypic groups of patients with suspected hereditary hemochromatosis.

Authors:  Paula Fernanda Silva Fonseca; Rodolfo Delfini Cançado; Flavio Augusto Naoum; Carla Luana Dinardo; Guilherme Henrique Hencklain Fonseca; Sandra Fatima Menosi Gualandro; José Eduardo Krieger; Alexandre Costa Pereira; Pierre Brissot; Paulo Caleb Junior Lima Santos
Journal:  BMC Med Genet       Date:  2018-01-05       Impact factor: 2.103

8.  Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients.

Authors:  Letícia C Tavares; Leiliane R Marcatto; Renata A G Soares; Jose E Krieger; Alexandre C Pereira; Paulo C J L Santos
Journal:  Front Pharmacol       Date:  2018-05-23       Impact factor: 5.810

9.  Investigation of genetic disturbances in oxygen sensing and erythropoietin signaling pathways in cases of idiopathic erythrocytosis.

Authors:  Carla Luana Dinardo; Paulo Caleb Junior Lima Santos; Isolmar Tadeu Schettert; Renata Alonso Gadi Soares; Jose Eduardo Krieger; Alexandre Costa Pereira
Journal:  Genet Res Int       Date:  2013-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.